Drug manufacturers developing OTC drugs have a lot of important decisions to make. One of these decisions is determining which regulatory pathway works best for their product.
Drug manufacturers developing OTC drugs have a lot of important decisions to make. One of these decisions is determining which regulatory pathway works best for their product. In this episode, Darshan discusses how the OTC monograph process takes place, and when drugs are considered safe and effective.
[et_pb_section fb_built=”1″ _builder_version=”3.29.3″ custom_padding=”||5px|||” fb_built=”1″ _i=”0″ _address=”0″][et_pb_row _builder_version=”3.29.3″ module_alignment=”center” collapsed=”off” _i=”0″ _address=”0.0″][et_pb_column type=”4_4″ _builder_version=”3.29.3″ _i=”0″ _address=”0.0.0″][et_pb_audio audio=”https://media.blubrry.com/darshantalks/content.blubrry.com/darshantalks/678547701-darshantalks-what-is-the-otc-monograph-process.mp3″ title=”@ET-DC@eyJkeW5hbWljIjp0cnVlLCJjb250ZW50IjoicG9zdF90aXRsZSIsInNldHRpbmdzIjp7ImJlZm9yZSI6IiIsImFmdGVyIjoiIn19@” artist_name=”@ET-DC@eyJkeW5hbWljIjp0cnVlLCJjb250ZW50IjoicG9zdF9hdXRob3IiLCJzZXR0aW5ncyI6eyJiZWZvcmUiOiIiLCJhZnRlciI6IiIsIm5hbWVfZm9ybWF0IjoiZGlzcGxheV9uYW1lIiwibGluayI6Im9mZiIsImxpbmtfZGVzdGluYXRpb24iOiJhdXRob3JfYXJjaGl2ZSJ9fQ==@” album_name=”DarshanTalks” _builder_version=”3.29.3″ _dynamic_attributes=”title,artist_name” background_color=”rgba(0,0,0,0)” background_layout=”light” custom_padding=”52px||22px|||” hover_enabled=”0″ border_color_all_image=”rgba(0,0,0,0)” _i=”0″ _address=”0.0.0.0″][/et_pb_audio][et_pb_text _builder_version=”3.29.3″ background_size=”initial” background_position=”top_left” background_repeat=”repeat” custom_margin=”-18px||15px|||” hover_enabled=”0″ _i=”1″ _address=”0.0.0.1″]
